# Impact of Virtual Reality Headset on Pain and Anxiety for Bedside Abdominal VAC Dressing Change (VIRPA): A Randomized Controlled Clinical Trial

**Authors:** Beatriz Barberá‐Carbonell, Amaniel Kefleyesus, Reza Djafarrian, Sandrine Geinoz, Dieter Hahnloser, Fabian Grass, Martin Hübner

PMC · DOI: 10.1002/hsr2.71877 · Health Science Reports · 2026-02-22

## TL;DR

This study tested if virtual reality (VR) helps reduce pain and anxiety during a medical procedure called VAC dressing change, but found no significant difference compared to standard care.

## Contribution

The study is the first to evaluate VR as a distraction tool specifically for VAC dressing changes in a clinical trial setting.

## Key findings

- VR use during VAC dressing changes did not significantly reduce pain or anxiety compared to standard care.
- Anxiety levels decreased significantly in both groups after the procedure.
- Patients reported high satisfaction with the standard pain protocol, regardless of VR use.

## Abstract

Virtual reality (VR) distraction techniques are promising adjuncts to reduce pain and anxiety. This study assessed the impact of VR distraction during bedside change of vacuum assisted closure (VAC) dressings.

In this non‐blinded randomized superiority trial, patients scheduled for bedside change of a subcutaneous VAC dressing were allocated to receive distraction through VR masks in addition to a standardized pain protocol (intervention) or pain protocol alone (control). Primary endpoints were pain scores assessed by a visual analogue scale (VAS: 0–10), secondary outcomes were anxiety (State Trait Anxiety Inventory (STAI), VAS: 0–10), hemodynamic parameters, and satisfaction (VAS: 0–10).

Pre‐ and postoperative pain levels were 2.2 ± 2.2 versus 2.0 ± 2.1 (p = 0.38) for the intervention group (21 patients) compared with 2.6 ± 2.1 versus 2.2 ± 1.6 (p = 0.26) for the control group (19 patients), with no significant difference between the groups (p = 0.38). No differences between the two groups were observed for blood pressure and heart rate (HR), besides lower post‐procedural HR in the intervention group. Anxiety was reduced in both groups post VAC change in the intervention and control group: STAI 40 ± 12 pre‐VAC versus 30 ± 8 post VAC and 45 ± 14 pre‐VAC versus 32 ± 9 post VAC (both p < 0.01), ∆VAS −2 (interquartile range IQR 0, −3) versus −2 (IQR 0, −5), both p < 0.01. Postinterventional satisfaction was 8.3 ± 1.9 (intervention) versus 7.5 ± 2.4 (p = 0.11).

Pain and anxiety were well managed within a standardized pain protocol, with or without adjunct VR distraction. While this may be due to limited statistical power in this exploratory pilot study, further studies should focus on patients with insufficient control of pain and anxiety with a standard protocol to assess the additional value of VR distraction.

Trial Registration: study registered in the FOPH portal SNCTP (Swiss National Clinical Trial): NCT04472416.

## Full-text entities

- **Diseases:** Pain (MESH:D010146), Anxiety (MESH:D001007), postoperative pain (MESH:D010149), burn (MESH:D002056), wound infections (MESH:D014946), infection (MESH:D007239), abdominal wounds (MESH:D000007), impaired cognitive status (MESH:D003072)
- **Chemicals:** Benzodiazepines (MESH:D001569)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12927986/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12927986/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC12927986/full.md

---
Source: https://tomesphere.com/paper/PMC12927986